Journal article
Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost–Utility Analysis
Abstract
IntroductionBudesonide orodispersible tablets (BOT) have been approved in Europe and Canada for the treatment of eosinophilic esophagitis (EoE), a rare and chronic disease. The objective of this study was to assess the economic impact of BOT on both the induction and maintenance of clinico-pathological remission of EoE by performing a cost–utility analysis (CUA).MethodsFor both the induction and maintenance settings, BOT was compared to no …
Authors
Beauchemin C; Castonguay A; Chan ES; Dellon ES; Feagan BG; Ma C; Waserman S; Cook J; Claveau D
Journal
Advances in Therapy, Vol. 38, No. 12, pp. 5737–5751
Publisher
Springer Nature
Publication Date
December 2021
DOI
10.1007/s12325-021-01957-7
ISSN
0741-238X